KP Tissue Inc.
KPTSF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1,113 | $2,571 | $1,747 | -$1,922 |
| Pre-Tax Income | $1,113 | $2,571 | $1,747 | -$1,922 |
| Tax Expense | $0 | $0 | $0 | $56 |
| Net Income | $1,113 | $2,571 | $1,747 | -$1,978 |
| % Margin | – | – | – | – |
| EPS | 0.11 | 0.26 | 0.17 | -0.2 |
| % Growth | -57.7% | 52.9% | 185% | – |
| EPS Diluted | 0.11 | 0.26 | 0.17 | -0.2 |
| Weighted Avg Shares Out | 10,007 | 9,999 | 10,276 | 9,973 |
| Weighted Avg Shares Out Dil | 10,007 | 10,000 | 10,276 | 9,973 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $72,478 | $75,768 | $66,760 |
| EBITDA | $82 | $72,478 | $75,768 | $66,760 |
| % Margin | – | – | – | – |